Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Weich

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Diagnostics (Basel, Switzerland)|April 3, 2021
CXCR4-Directed PET/CT in Patients with Newly Diagnosed Neuroendocrine CarcinomasAlexander Weich, Rudolf A Werner, Andreas K Buck, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 11, 2023
CXCR4-directed PET/CT with [<sup>68</sup> Ga]Ga-pentixafor in solid tumors-a comprehensive analysis of imaging findings and comparison with histopathologyNiklas Dreher, Stefanie Hahner, Carmina T Fuß, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 24, 2019
Novel Structured Reporting Systems for Theranostic RadiotracersRudolf A Werner, Ralph A Bundschuh, Lena Bundschuh, et al.
Plos One|March 19, 2013
Down-regulation of canonical and up-regulation of non-canonical Wnt signalling in the carcinogenic process of squamous cell lung carcinomaDomokos Bartis, Veronika Csongei, Alexander Weich, et al.
Cancers|July 29, 2023
In-Vivo Somatostatin-Receptor Expression in Small Cell Lung Cancer as a Prognostic Image Biomarker and Therapeutic TargetFeyza Şen, Gabriel T Sheikh, Johannes von Hinten, et al.
European Journal of Endocrinology|September 19, 2025
World first hybrid neuroendocrine cell line sharing properties of NET G3 and dedifferentiated NECDorothee Rogoll, Laura-Sophie Landwehr, Jochen Schreiner, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 5, 2023
Chemokine Receptor PET/CT Provides Relevant Staging and Management Changes in Marginal Zone LymphomaJohannes Duell, Andreas K Buck, Philipp E Hartrampf, et al.
Diagnostics (Basel, Switzerland)|November 27, 2021
Whole-Body [<sup>18</sup>F]FDG PET/CT Can Alter Diagnosis in Patients with Suspected Rheumatic DiseaseMatthias Fröhlich, Sebastian Serfling, Takahiro Higuchi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 4, 2022
Imaging of C-X-C Motif Chemokine Receptor 4 Expression in 690 Patients with Solid or Hematologic Neoplasms Using <sup>68</sup>Ga-Pentixafor PETAndreas K Buck, Alexander Haug, Niklas Dreher, et al.
Alimentary Pharmacology & Therapeutics|April 4, 2025
Therapeutic Sequences of Systemic Therapy After Atezolizumab Plus Bevacizumab for Hepatocellular Carcinoma: Real-World Analysis of the IMMUreal CohortNajib Ben Khaled, Valentina Zarka, Bernard Hobeika, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Diagnostics (Basel, Switzerland)|April 3, 2021
CXCR4-Directed PET/CT in Patients with Newly Diagnosed Neuroendocrine CarcinomasAlexander Weich, Rudolf A Werner, Andreas K Buck, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 11, 2023
CXCR4-directed PET/CT with [<sup>68</sup> Ga]Ga-pentixafor in solid tumors-a comprehensive analysis of imaging findings and comparison with histopathologyNiklas Dreher, Stefanie Hahner, Carmina T Fuß, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 24, 2019
Novel Structured Reporting Systems for Theranostic RadiotracersRudolf A Werner, Ralph A Bundschuh, Lena Bundschuh, et al.
Plos One|March 19, 2013
Down-regulation of canonical and up-regulation of non-canonical Wnt signalling in the carcinogenic process of squamous cell lung carcinomaDomokos Bartis, Veronika Csongei, Alexander Weich, et al.
Cancers|July 29, 2023
In-Vivo Somatostatin-Receptor Expression in Small Cell Lung Cancer as a Prognostic Image Biomarker and Therapeutic TargetFeyza Şen, Gabriel T Sheikh, Johannes von Hinten, et al.
European Journal of Endocrinology|September 19, 2025
World first hybrid neuroendocrine cell line sharing properties of NET G3 and dedifferentiated NECDorothee Rogoll, Laura-Sophie Landwehr, Jochen Schreiner, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 5, 2023
Chemokine Receptor PET/CT Provides Relevant Staging and Management Changes in Marginal Zone LymphomaJohannes Duell, Andreas K Buck, Philipp E Hartrampf, et al.
Diagnostics (Basel, Switzerland)|November 27, 2021
Whole-Body [<sup>18</sup>F]FDG PET/CT Can Alter Diagnosis in Patients with Suspected Rheumatic DiseaseMatthias Fröhlich, Sebastian Serfling, Takahiro Higuchi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 4, 2022
Imaging of C-X-C Motif Chemokine Receptor 4 Expression in 690 Patients with Solid or Hematologic Neoplasms Using <sup>68</sup>Ga-Pentixafor PETAndreas K Buck, Alexander Haug, Niklas Dreher, et al.
Alimentary Pharmacology & Therapeutics|April 4, 2025
Therapeutic Sequences of Systemic Therapy After Atezolizumab Plus Bevacizumab for Hepatocellular Carcinoma: Real-World Analysis of the IMMUreal CohortNajib Ben Khaled, Valentina Zarka, Bernard Hobeika, et al.
Pageof 6